Home › Funds › KINGDON CAPITAL MANAGEMENT, L.L.C. › OLMA

KINGDON CAPITAL MANAGEMENT, L.L.C. position in OLMA

OLEMA PHARMACEUTICALS INC · Health Care

KINGDON CAPITAL MANAGEMENT, L.L.C. reported holding 1,200,000 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$15.0M, representing 1.65% of its reported portfolio and ranking #19 among its reported holdings. KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed OLMA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.20M sh
Reported value held$15.01M
Portfolio Weight1.65%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KINGDON CAPITAL MANAGEMENT, L.L.C.'s OLMA position evolved

KINGDON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in OLMA in Q3 2023 at 98,600 shares (US$1.2M). The position peaked in Q4 2025 at 953,600 shares, worth US$23.8M. Across 6 filings, KINGDON CAPITAL MANAGEMENT, L.L.C. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,200,000 shares valued at US$15.0M — an increase of 345,000 shares quarter over quarter.. Notable position changes include a 154% increase in Q4 2023 (shares fell 19% over the following quarter), a 40% increase in Q2 2026 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 98.60K $1.22M New
Q4 2023 250.00K $3.51M Add
Q3 2025 854.00K $8.36M New
Q4 2025 953.60K $23.84M Add
Q1 2026 855.00K $12.75M Reduce
Q2 2026 1.20M $15.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OLMA and 13F data

OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OLMA

All OLMA fund holders →

FAQ

How long has KINGDON CAPITAL MANAGEMENT, L.L.C. held OLMA?

KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed OLMA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is KINGDON CAPITAL MANAGEMENT, L.L.C.'s current position in OLMA?

As of Q2 2026, KINGDON CAPITAL MANAGEMENT, L.L.C. holds 1.20M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $15.01M, representing 1.65% of its reported portfolio and ranking #19.

Has KINGDON CAPITAL MANAGEMENT, L.L.C. been buying or selling OLMA?

In the latest 13F filing (Q2 2026), KINGDON CAPITAL MANAGEMENT, L.L.C. increased its position in OLMA. The position peaked in Q4 2025 at 953.60K shares.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.